Maryanne Maunsell Farris's Insider Trades & SAST Disclosures

Maryanne Maunsell Farris's most recent trade in Haemonetics Corp. was a trade of 1,291 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 17, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Haemonetics Corp.
Maryanne Maunsell Farris VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 1,291 1,291 - - Non-qualified Stock Option (Right to Buy)
Haemonetics Corp.
Maryanne Maunsell Farris VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 587 1,144 (0%) 0% - Common Stock
Haemonetics Corp.
Maryanne Maunsell Farris VP, Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.49 per share. 15 May 2024 73 557 (0%) 0% 96.5 7,044 Common Stock
Haemonetics Corp.
Maryanne Maunsell Farris VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2023 1,425 1,425 - - Non-qualified Stock Option (Right to Buy)
Haemonetics Corp.
Maryanne Maunsell Farris VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2023 630 630 (0%) 0% - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades